Deutsche Bank Ag\ Vaxcyte, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 1,148,184 shares of PCVX stock, worth $99.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,148,184

Previous 130,062 782.8%

Holding current value

$99.4 Million

Previous $9.82 Million 1234.91%

% of portfolio

0.05%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$70.52 - $117.12 $71.8 Million - $119 Million	1,018,122 Added 782.8%	1,148,184 $131 Million
Q2 2024 Aug 14, 2024	SELL	$60.06 - $78.77 $365,525 - $479,394	-6,086 Reduced 4.47%	130,062 $9.82 Million
Q1 2024 May 15, 2024	SELL	$59.79 - $81.05 $963,216 - $1.31 Million	-16,110 Reduced 10.58%	136,148 $9.3 Million
Q4 2023 Feb 14, 2024	BUY	$45.35 - $63.41 $3.5 Million - $4.89 Million	77,179 Added 102.8%	152,258 $9.56 Million
Q3 2023 Nov 09, 2023	BUY	$46.0 - $53.1 $1.48 Million - $1.7 Million	32,099 Added 74.68%	75,079 $3.83 Million
Q2 2023 Aug 14, 2023	SELL	$34.66 - $54.07 $226,988 - $354,104	-6,549 Reduced 13.22%	42,980 $2.15 Million
Q1 2023 May 15, 2023	BUY	$36.27 - $47.2 $509,013 - $662,404	14,034 Added 39.54%	49,529 $1.86 Million
Q4 2022 Feb 13, 2023	BUY	$20.58 - $47.95 $240,127 - $559,480	11,668 Added 48.97%	35,495 $1.7 Million
Q3 2022 Nov 14, 2022	SELL	$21.69 - $28.53 $57,782 - $76,003	-2,664 Reduced 10.06%	23,827 $572,000
Q2 2022 Aug 11, 2022	BUY	$17.68 - $26.58 $38,984 - $58,608	2,205 Added 9.08%	26,491 $576,000
Q1 2022 May 13, 2022	SELL	$17.46 - $26.36 $100,534 - $151,780	-5,758 Reduced 19.17%	24,286 $587,000
Q4 2021 Feb 11, 2022	BUY	$19.32 - $26.45 $26,429 - $36,183	1,368 Added 4.77%	30,044 $714,000
Q3 2021 Nov 04, 2021	SELL	$20.26 - $26.97 $20,847 - $27,752	-1,029 Reduced 3.46%	28,676 $727,000
Q2 2021 Aug 11, 2021	BUY	$16.45 - $24.06 $173,465 - $253,712	10,545 Added 55.04%	29,705 $668,000
Q1 2021 May 13, 2021	BUY	$18.66 - $29.16 $100,353 - $156,822	5,378 Added 39.02%	19,160 $378,000
Q4 2020 Feb 16, 2021	BUY	$26.57 - $51.74 $107,475 - $209,288	4,045 Added 41.54%	13,782 $366,000
Q3 2020 Nov 12, 2020	BUY	$26.5 - $55.4 $258,030 - $539,429	9,737 New	9,737 $481,000

Others Institutions Holding PCVX

# of Institutions

353

Shares Held

122M

Call Options Held

775K

Put Options Held

433K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.13B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account